首页|基于FAERS数据库对儿童使用头孢曲松的不良事件分析

基于FAERS数据库对儿童使用头孢曲松的不良事件分析

扫码查看
目的 挖掘分析真实世界中儿童使用头孢曲松的药物不良事件(ADE)信号,为儿童使用头孢曲松的安全性评估提供参考。方法 提取美国食品和药物管理局不良事件报告系统(FAERS)中2004年第一季度至2022年第三季度以头孢曲松为首要怀疑药物的0~17岁儿童的ADE报告,利用国际医学用语词典(MedDRA)对ADE进行器官系统归类,采用报告比值比(ROR)法和比例报告比值比(PRR)法挖掘头孢曲松ADE信号。结果 收集到0~17岁儿童中以头孢曲松为首要怀疑药物的ADE报告共999份,相关ADE信号139个,累及18个器官系统。发生频次前3位ADE分别为急性肾损伤、胆石症和肾后性肾衰竭;信号强度前3位ADE分别为肾后性肾衰竭、输尿管结石和血管内溶血。各年龄段儿童头孢曲松信号强度前10位ADE均主要累及肝胆系统、肾脏及泌尿系统和血液及淋巴系统。2007年7月头孢曲松说明书更新后,头孢曲松所致儿童结石类ADE在全部ADE中所占构成比由5。88%降至5。61%。ADE报告中联合用药排名前10位的药物以其他类型的抗生素和非甾体抗炎药为主。结论 头孢曲松在儿童中应用时,应警惕其对肝胆和肾脏系统可能造成的不良事件,同时注意与其他药物联合使用带来的不良事件风险。
Analysis of adverse drug events of ceftriaxone in children based on FAERS database
AIM To investigate and analyze the adverse drug event(ADE)signals associated with ceftriaxone in children in the real world,and provide references for the safety evaluation of ceftriaxone in children.METHODS ADE reports in the US FDA Adverse Event Reporting System(FAERS)from the first quarter of 2004 to the third quarter of 2022 involving children aged 0-17 years with ceftriaxone as the primary suspected drug were extracted.ADEs were classified into organ systems using the Medical Dictionary for Regulatory Activities(MedDRA).The reporting odds ratio(ROR)and proportional reporting ratio(PRR)methods were utilized to identify ADE signals associated with ceftriaxone.RESULTS A total of 999 ADE reports were collected for children aged 0-17 years with ceftriaxone as the primary suspected drug.There were 139 related ADE signals affecting 18 organ systems.The top 3 ADEs in terms of frequency were acute kidney injury,cholelithiasis,and postrenal acute renal failure.The top 3 ADEs in terms of signal strength were postrenal acute renal failure,ureteral calculus,and intravascular hemolysis.The top 10 ADEs in terms of signal strength for ceftriaxone in different age groups of children primarily involved the hepatobiliary system,renal and urinary system,and the blood and lymphatic system.After the update of the ceftriaxone package insert in July 2007,the proportion of pediatric stone-related ADEs caused by ceftriaxone decreased from 5.88%to 5.61%among all ADEs.Among the top 10 concomitant medications reported in ADEs,other types of antibiotics and nonsteroidal anti-inflammatory drugs were the most commonly used.CONCLUSION When ceftriaxone is used in children,caution should be exercised regarding its potential adverse events on the liver,gallbladder,and renal system.Additionally,attention should be paid to the risk of adverse events when used in combination with other medications.

ceftriaxonedrug monitoringdata miningchildadverse drug eventFAERS database

张烨、张远、杨明华、王胜峰

展开 >

中南大学湘雅三医院 儿科,湖南长沙 410013

中南大学湘雅三医院 药学部,湖南长沙 410013

头孢曲松 药物监测 数据挖掘 儿童 药物不良事件 FAERS数据库

长沙市自然科学基金

kq2202421

2024

中国新药与临床杂志
中国药学会 上海市食品药品监督管理局科技情报研究所

中国新药与临床杂志

CSTPCD北大核心
影响因子:0.967
ISSN:1007-7669
年,卷(期):2024.43(6)
  • 27